New Hope to Restore Vision back in case of Retinitis Pigmentosa Eye Genetic Disease - Eye Stem Cell Center

The rare eye conditions known as retinal pigmentosa (RP) are characterized by damage to the retina, which is the back of the eye’s light-sensitive layer of tissue. Vision loss results from RP’s slow-motion destruction of retinal pigment cells.

People are born with RP, a hereditary disorder, most people lose most of their sight gradually, with symptoms typically beginning in childhood.

RP has no known treatment. However, people with RP can maximize their visual potential with the use of vision aids and rehabilitation (training) programs.

Symptoms of Retinitis Pigmentosa: –

Loss of vision: – When you are blind in the dark, you are said to have night blindness. During the day, your eyesight can be normal. You take longer to adjust to the dark after you begin to lose your night vision. You could stumble over things or find it difficult to drive at night or in the dark. In poorly light areas like movie theaters, you could also be difficult to see.

Gradual loss of side vision, or peripheral vision: –  We call this “tunnel vision”. Things may collide with you while you’re moving. This is a result of your inability to see what you are below and around.

 Loss of vision: –  A few people also experience issues with their center vision. This can make intricate tasks challenging, like reading or threading a needle. Issues with color vision. After some time, you will become completely blind.

Diagnoses and Tests of Retinitis Pigmentosa: –

• Electroretinography (ERG) Test: – A test called electroretinography gauges how your retina reacts to light. It examines the various retinal cells’ functionalities. To assess the activity of your retina, your healthcare professional will flash lights in front of your eyes. One kind of ocular electrophysiology test is electroretinography. By monitoring the electrical activity in your retinas, optic nerves, and brain’s visual pathways, these tests can determine how well your eyes and brain interpret what you see.
• Optical Coherence Tomography (OCG): – OCT is a painless test that can gauge the thickness of your retina and break down the retinal respectability. You are approached to view at an objective as an exceptional camera takes a picture of the rear of your eye.
• Genetic Testing: – This test takes a gander at an example of your blood or different tissues to check whether you have specific qualities that are related with an infection. It can likewise assist with deciding the reasonable course or seriousness of an illness and whether quality treatment to supplant the defective quality might be useful.

New Advancement for RP Disease: –

As of now, there is no particular treatment for retinitis pigmentosa. But gene therapy is in research which will take time to come because there are so many gene involved and even some particular gene related retinal dystrophy disease is curable but it’s very much limited and it will take so many years to come fully in market. Otherwise there is only one stem cell treatment for Retinitis pigmentosa patients in United kingdom which is one of best treatment to keep stability and improve some percent of vision back.

ROLE OF STEM CELL: –

As of now that there are so many “Retinitis pigmentosa patients in United kingdom” and our advanced stem cell treatment is very much effective for “Retinitis pigmentosa treatment in united kingdom”. Stem cell therapy for Retinitis Pigmentosa (RP) involves using stem cells to replace or repaired damaged retinal cells. The idea is to introduce healthy cells into retina to improve or restore vision. Studies and clinical trials are exploring the potential of both embryonic and adult stem cells in treating RP.

Stem cells can differentiate into retinal cells, such as photoreceptors, which are crucial for vision. By transplanting these cells into the damaged retina, there’s hope for restoring lost function and slowing down the progression of RP. However, it’s important to note that while there’s ongoing research, this therapy is still in the experimental stage, and its long-term effectiveness and safety are being studied.

Stem cell therapy is not only about replacing damaged cells but also addressing the inflammatory and immune responses that contribute to RP progression. Mesenchymal stem cells have modulatory properties, suppressing inflammatory responses and creating an environment conductive to tissue repair.

Clinical trials exploring the safety and efficacy of stem cell therapies for RP are underway. However, challenges such as ensuring proper integration of transplanted cells, long-term stability, avoiding adverse effect need through investigations.